﻿The pathophysiologic and clinical significance of anti-thyroglobulin autoantibodies in patients with sarcoidosis is not clear, but it may be interpreted as a non-specific feature of a systemic autoimmune activation, characteristic of sarcoidosis. Here, TG is linked to sarcoidosis.